drugset / Trial / NCT05571163
A Study to Evaluate the Relative Bioavailability of AMG 510 Administered as Tablets and as a Water Dispersion in Healthy Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The primary objective of the study is to evaluate the pharmacokinetics (PK) of AMG 510 administered as 8 x 120-mg tablets and as water dispersion in healthy participants.
Timeline
- Start
- 2020-03-06
- Primary completion
- 2020-06-14
- Completion
- 2020-06-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sotorasib | Small molecule | 960 mg | Oral |
Indications
No indication recorded.